Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018
Revenues:
Obstructive sleep apnea (OSA)	$ 90,453	$ 169,944	$ 158,376	$ 350,567
Total revenues	90,453	169,944	158,376	350,567
Costs and expenses:
Costs of revenues	66,157	185,245	107,817	234,344
General and administrative	416,039	513,012	841,843	987,059
Depreciation and amortization	235	150	440	300
Total costs and expenses	482,431	698,407	950,100	1,221,703
Loss from operations	(391,978)	(528,463)	(791,724)	(871,136)
Other income (expense):
Interest expense	(341,178)	(408,747)	(669,193)	(840,873)
Interest income	5,994		5,994
Legal settlement	112,172	328,269	112,172	328,269
Extinguishment of loan due to shareholder		7,771,140		7,771,140
Settlement of prior accounting services				(240,000)
Other income				2,380
Total other income (expense)	(223,012)	7,690,662	(551,027)	7,020,916
Income taxes
Net (loss) income	$ (614,990)	$ 7,162,199	$ (1,342,751)	$ 6,149,780
PER SHARE INFORMATION
Net (Loss) Income Per Common Share	$ (0.01)	$ 0.11	$ (0.02)	$ 0.09
Weighted Average Number of Common Shares Outstanding	67,361,656	66,573,855	67,027,954	65,436,202